US Stock MarketDetailed Quotes

ELTX Elicio Therapeutics

Watchlist
  • 8.980
  • -0.020-0.22%
Close May 3 16:00 ET
91.88MMarket Cap-2450P/E (TTM)

Elicio Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Elicio Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.93

+95.55%
Analyst Rating

Buy

May 1, 2024

Elicio Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--

Elicio Therapeutics Earnings Reports

  • Elicio Therapeutics | 10-K/A: Annual report (Amendment)

    Apr 29 07:02 ET

  • Elicio Therapeutics | 10-K: Annual report

    Mar 29 14:02 ET

  • Elicio Therapeutics | 10-Q: Quarterly report

    Nov 13, 2023 08:45 ET

  • Elicio Therapeutics | 10-Q: Quarterly report

    Aug 11, 2023 21:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 1, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg